Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
Rhea-AI Summary
Progyny (NASDAQ: PGNY) will report results for the quarter ended March 31, 2026, after market close on Thursday, May 7, 2026. A conference call will follow at 4:45 p.m. ET (1:45 p.m. PT). A press release will be issued before the call and a live webcast and archived replay will be available on the investor website.
Positive
- None.
Negative
- None.
News Market Reaction – PGNY
In the Apr 23 session, PGNY declined 1.78%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Q4/FY25 earnings | Positive | -20.5% | Reported Q4 and FY 2025 results with revenue growth and solid profitability. |
| Feb 12 | Earnings date notice | Neutral | -2.6% | Announced timing and access details for Q4 and FY 2025 results call. |
| Nov 06 | Q3 2025 earnings | Positive | +24.2% | Reported Q3 2025 revenue and EBITDA growth with raised full‑year guidance. |
| Oct 23 | Earnings date notice | Neutral | +1.7% | Provided reporting date and call logistics for Q3 2025 financial results. |
| Aug 07 | Q2 2025 earnings | Positive | -0.9% | Announced strong Q2 2025 revenue, net income, and raised full‑year guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings result releases for PGNY have produced mixed reactions, including sharp downside after strong numbers, while simple "results date" announcements typically saw modest, directionally muted moves.
Over the past year, PGNY’s earnings-related news has ranged from strong quarterly results to simple scheduling notices. Q2 and Q3 2025 earnings showed solid revenue and EBITDA but led to very different price reactions, including a -20.49% move on Feb 26, 2026 despite positive FY 2025 metrics. By contrast, prior “details for results report” releases on Feb 12, 2026 and Oct 23, 2025 generated only small moves. Today’s first‑quarter 2026 reporting notice fits that latter pattern of primarily informational disclosures.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026.
The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, May 14, 2026, and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
